[HTML][HTML] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Heart Failure: An Umbrella Review
R Roy, S Vinjamuri, RB Salian, N Hafeez… - Cureus, 2023 - ncbi.nlm.nih.gov
Heart failure remains a leading cause of hospitalization and death, and presents a
significant challenge for healthcare providers despite the advancements in its management …
significant challenge for healthcare providers despite the advancements in its management …
[PDF][PDF] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Heart Failure: An Umbrella Review
R Roy, S Vinjamuri, RB Salian, N Hafeez… - 2023 - researchgate.net
Heart failure remains a leading cause of hospitalization and death, and presents a
significant challenge for healthcare providers despite the advancements in its management …
significant challenge for healthcare providers despite the advancements in its management …
[PDF][PDF] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Heart Failure: An Umbrella Review
R Roy, S Vinjamuri, RB Salian, N Hafeez… - Cureus, 2023 - cureus.com
Heart failure remains a leading cause of hospitalization and death, and presents a
significant challenge for healthcare providers despite the advancements in its management …
significant challenge for healthcare providers despite the advancements in its management …
Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Heart Failure: An Umbrella Review
R Roy, V Saketh, BS Rishabh, H Nosheen… - Cureus, 2023 - search.proquest.com
Heart failure remains a leading cause of hospitalization and death, and presents a
significant challenge for healthcare providers despite the advancements in its management …
significant challenge for healthcare providers despite the advancements in its management …
Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Heart Failure: An Umbrella Review
R Roy, S Vinjamuri, N Hafeez, T Patel, T Gudi… - Cureus, 2023 - europepmc.org
Heart failure remains a leading cause of hospitalization and death, and presents a
significant challenge for healthcare providers despite the advancements in its management …
significant challenge for healthcare providers despite the advancements in its management …
Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Heart Failure: An Umbrella Review
R Roy, S Vinjamuri, RB Salian, N Hafeez… - Cureus, 2023 - pubmed.ncbi.nlm.nih.gov
Heart failure remains a leading cause of hospitalization and death, and presents a
significant challenge for healthcare providers despite the advancements in its management …
significant challenge for healthcare providers despite the advancements in its management …
[PDF][PDF] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Heart Failure: An Umbrella Review
R Roy, S Vinjamuri, RB Salian, N Hafeez… - 2023 - assets.cureus.com
Heart failure remains a leading cause of hospitalization and death, and presents a
significant challenge for healthcare providers despite the advancements in its management …
significant challenge for healthcare providers despite the advancements in its management …
Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Heart Failure: An Umbrella Review.
R Roy, S Vinjamuri, N Hafeez, T Patel, TR Gudi… - Cureus, 2023 - europepmc.org
Heart failure remains a leading cause of hospitalization and death, and presents a
significant challenge for healthcare providers despite the advancements in its management …
significant challenge for healthcare providers despite the advancements in its management …
[PDF][PDF] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Heart Failure: An Umbrella Review
R Roy, S Vinjamuri, RB Salian, N Hafeez… - 2023 - assets.cureus.com
Heart failure remains a leading cause of hospitalization and death, and presents a
significant challenge for healthcare providers despite the advancements in its management …
significant challenge for healthcare providers despite the advancements in its management …